Andy Rust

Andy works with cross-functional teams and external partners to deliver impactful and sustainable solutions.

A founding director at Potyque Limited, Andy is committed to advancing the field of medicine, creating value for companies, the healthcare system, and patients.  

He brings over 30 years commercial experience in the healthcare sector, the most recent of which being 10 years international experience with Chiesi Group as Global Head of Respiratory. He led the strategic direction and execution of the company's respiratory portfolio, which included innovative products for asthma and COPD, as well a pipeline of novel drug candidates supported by a drug delivery platform of formulation and device technologies. This followed earlier years at Kyowa Kirin and Organon.

He is  committed to advancing the field of medicine, creating value for companies, the healthcare system, and patients through strategic board advisory, taking a people-focused approach serving as an influential leader, enjoying shaping solutions that respond to evolving situations. 

With deep insights into the strategic and revenue challenges facing the cannabinoid market he believes in the huge potential of the molecule.